LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework

14/09/2023

POSITION PAPER

Brussels, 8 September 2023

The European Commission’s proposal for plants produced by certain new genomic techniques (NGT legislation) is a sign of its commitment to timely and relevant policymaking to ensure food security and tackle environmental challenges such as climate change and biodiversity loss.
The GMO framework has implications for the EU’s global competitiveness and desire for greater resiliency against climate and geopolitical dynamics. As the EU modernizes its GMO Framework, it must urgently assess and take into account scientific and technological developments in all GMO-related legislation which will inevitably be impacted.
In this context, there are urgent scientific and economic reasons to further adapt the GMO framework for genetically modified microorganisms (GMMs). Globally, other jurisdictions are developing enabling frameworks that provide the needed regulatory certainty for industry and allow innovative products to access the market. By addressing GMMs in the GMO framework, the EU can lay out a pragmatic approach for novel products that will grow the EU’s resilience and competitiveness.

Europe cannot afford a delay in legislation for GMMs
Our policy asks:
• Include in the NGT legislation a commitment for the EC to publish a proposal for additional policy actions on genetically modified microorganisms (GMMs) by 2024.
• Accelerate the overall revision of the GMO framework across sectors beyond plants - to be in line with existing scientific advances.
This would help increase the Union strategic autonomy by developing novel products which contribute to the resilience of agri-food systems while reducing their environmental footprint.

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.